Quick Takeaways
- VANGUARD GROUP INC filed SCHEDULE 13G/A for PTC Therapeutics Inc Common Stock (PTCT).
- Disclosed ownership: 10%.
- Date of event: 30 Sep 2025.
VANGUARD GROUP INC - 30 Sep 2025 SCHEDULE 13G/A Report for PTC Therapeutics Inc Common Stock (PTCT)
- Filing Manager
- VANGUARD GROUP INC
- Reporting Manager
- The Vanguard Group
- Security
- PTC Therapeutics Inc Common Stock
- Symbol
- PTCT
- Shares outstanding
- 79,472,665 shares
- Disclosed Ownership
- 8,288,999 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Oct 2025, 15:49:09 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 27 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"VANGUARD GROUP INC disclosed 10% ownership in PTC Therapeutics Inc Common Stock (PTCT) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Oct 2025, 15:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Vanguard Group | 10% | 8,288,999 | 0 | 530,520 | Ashley Grim | Head of Global Fund Administration |